Pediatric Blood & Cancer 2010-07-15

Stanozolol treatment for successful prevention of attacks of severe primary cryofibrinogenemia.

Sule Unal, Fehime Kara, Seza Ozen, Diclehan Orhan, Murat Tuncer, Fatma Gumruk

Index: Pediatr. Blood Cancer 55(1) , 174-6, (2010)

Full Text: HTML

Abstract

Severe essential cryofibrinogenemia is rare in childhood, and both the diagnosis and the management are challenging for pediatricians. An 11-year-old male, who had already lost two digits following cold exposure, was referred after multiple visits to various hospitals and subsequently diagnosed as primary cryofibrinogenemia. His history revealed unresponsiveness to calcium channel blockers, acetyl salicylic acid, pentoxifylline, dextran, and steroids. Stanozolol (2 mg/day, orally) prophylaxis was initiated and no new skin lesions developed following starting this treatment. Some of the newly formed lesions at the onset of stanozolol healed.

Related Compounds

  • Stanozolol

Related Articles:

High throughput quantification of prohibited substances in plasma using thin film solid phase microextraction.

2014-12-29

[J. Chromatogr. A. 1374 , 40-9, (2014)]

Screening for anabolic steroids in urine of forensic cases using fully automated solid phase extraction and LC-MS-MS.

2014-01-01

[J. Anal. Toxicol. 38(9) , 637-44, (2014)]

Quantitative determination of 26 steroids in eggs from various species using liquid chromatography-triple quadrupole-mass spectrometry.

2014-08-22

[J. Chromatogr. A. 1356 , 54-63, (2014)]

[Ingestion of anabolic steroids and ischaemic stroke. A clinical case report and review of the literature].

2013-03-16

[Rev. Neurol. 56(6) , 327-31, (2013)]

Current management options for hereditary angioedema.

2012-08-01

[Curr. Allergy Asthma Rep. 12(4) , 273-80, (2012)]

More Articles...